Safety in production, no day, no day, no day, no time, no time, no time, no time, no time, no time, no time to take precautions
Release time:
2020-08-14
Safety Production No Competition Day Always Alert
After the "Safety Production Month" Ends
□ This newspaper commentator
7# In early 15, the "Safety Production Month" series of activities of the subordinate units of the group company came to an end one after another. Although some activities had to be postponed due to the impact of continuous heavy rains, in general, publicity, training, drills, and essays were carried out in an orderly manner, and the results were considered satisfactory and achieved the expected goals and effects. However, the safety production month is over, but the safety production work will not come to an end, because it is a long-term, continuous, never-ending, and never perfect work.
We often say that the goal of an enterprise is to maximize production, operation, and efficiency. The most critical goal is to develop and grow, and the development of an enterprise must be guaranteed by safety. If there is no basis for safety, no matter how advanced the management methods are, no matter how advanced the technology is, and no matter how advanced the facilities and equipment are, they are just empty words. The results of thousands of people working hard day and night can be wiped out in an instant in just one accident. Therefore, only when safety is guaranteed can the enterprise truly have vitality and development power, and it is possible to promote production and operation to continuously create brilliance.
Since 2015 , under the leadership of the Party Central Committee and the State Council, all regions, relevant departments and units across the country have conscientiously implemented the spirit of the important instructions and instructions of General Secretary Xi Jinping, Premier Li Keqiang and other leading comrades of the Party Central Committee and the State Council on strengthening production safety, profoundly draw lessons from accidents, take public security according to law as the main line, deepen governance and rectification, and strengthen inspection and supervision, the situation of domestic production safety has greatly improved compared with the past. As far as our peak is concerned, on the basis of previous safety production management, starting from , 2014 , the establishment of "safety and environmental protection accident-free factory", all subordinate enterprises actively carried out relevant publicity and training, strengthened the safety and environmental protection awareness of all employees, increased investment in safety and environmental protection facilities and equipment, strengthened self-examination and self-correction of hidden dangers, and improved various emergency plans... This series of work has strongly promoted the company's safe and civilized production construction, it is also far beyond the scope of the annual safety production month theme. In other words, we invest heavily and pay attention to safety on a large scale, not to cope with the inspection and supervision of government departments, nor to make a show in response to the situation, but to be truly responsible for the enterprise, employees, and employees' families. After all, only by being safe can we truly hold the results of our efforts in our hands, and let everyone truly enjoy the dividends brought by enterprise development. The annual production safety month of
is a time for intensive publicity of production safety throughout the country, especially in enterprises. However, as mentioned above, safety production runs through every link of enterprise operation and management, and is related to every post, every employee, and even every work detail. Therefore, the end of the safe production month of 2017 may give us a little relief, but in our thoughts and behaviors, we must not let go of the string of safety!
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31